At present, there are only two kinds of mature biomedical engineering technology products to solve arrhythmia clinically:
1. Patients with malignant arrhythmia in the early, middle and early stages can be completely controlled or cured by the cellular gene energy therapeutic instrument.
2. Patients who are already in the middle and late stage of malignant arrhythmia should immediately wear pacemakers in tertiary hospitals, which can fully control the arrhythmia and ensure the normal heart of patients.
It is especially suggested that patients with arrhythmia should not use radiofrequency ablation, that is, it is wrong to cut off the cardiac current conduction pathway (nerve) to stop arrhythmia symptoms. So far, there has not been a case of rehabilitation.
Sun Ping